What is the risk of cross-sensitivity between cephalexin and amoxicillin (amoxicillin) in patients with a penicillin allergy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cross-Sensitivity Between Cephalexin and Amoxicillin in Patients with Penicillin Allergy

For patients with penicillin allergy, there is a significant risk of cross-sensitivity with cephalexin (12.9%) due to similar side chain structures, particularly in those with confirmed amino-penicillin (amoxicillin) allergy. 1

Risk Factors for Cross-Reactivity

  • Cross-reactivity between penicillins and cephalosporins is primarily determined by the similarity of their R1 side chains, rather than the β-lactam ring itself 1
  • Cephalexin has been specifically identified as having a significantly increased absolute risk of cross-reactivity (12.9%) in patients with penicillin allergy 1
  • The FDA label for cephalexin warns that cross-hypersensitivity among beta-lactam antibiotics may occur in up to 10% of patients with a history of penicillin allergy 2
  • Cross-reactivity is higher for amino-cephalosporins (which include cephalexin) that share an identical side chain with a penicillin (16.45%, 95% CI, 11.07-23.75) 1

Type of Allergic Reaction and Cross-Reactivity Risk

Immediate-Type Reactions (IgE-mediated)

  • For patients with suspected immediate-type allergy to penicillins, cephalosporins with dissimilar side chains can be used regardless of severity or time since reaction 1
  • Patients with a non-severe immediate-type reaction to penicillin >5 years ago may receive cephalosporins with similar side chains (like cephalexin) in a controlled setting 1
  • The higher risk of cross-reactivity with amino-cephalosporins is observed in both IgE-mediated (immediate) and T-cell-mediated (delayed) penicillin allergies 1

Delayed-Type Reactions

  • For patients with suspected non-severe, delayed-type allergy to penicillins, cephalosporins with dissimilar side chains can be used 1
  • Guidelines specifically suggest avoiding cephalosporins with similar side chains (including cephalexin) in patients with suspected non-severe, delayed-type allergy to amoxicillin 1

Specific Relationship Between Amoxicillin and Cephalexin

  • There is a strong association between amoxicillin and first-generation cephalosporins (like cephalexin) that share a similar R1 side chain 3
  • Patients with positive amoxicillin-IgE show significantly higher rates of specific-cephalexin IgE (14.00% vs. 2.96%) compared to those with negative amoxicillin-IgE 4
  • Recent evidence indicates a higher risk of cross-reactivity with cephalexin specifically in patients with confirmed amino-penicillin (amoxicillin, ampicillin) allergy 5

Clinical Approach Based on Allergy History

  • For patients with documented penicillin allergy, the risk of cross-reactivity with cephalosporins that have dissimilar side chains is negligible (<1%) 1
  • Cefazolin does not share any side chains with currently available penicillins and can be safely used in cases of suspected penicillin allergy 1
  • The overall cross-reactivity rate between penicillins and first-generation cephalosporins is approximately 1% (much lower than the previously reported 10%), except when using cephalosporins with similar R1 side chains 3
  • Current evidence suggests that the rate of cross-reactivity between penicillin and cephalosporins is about 2%, lower than the 8% previously reported 6

Common Pitfalls and Caveats

  • Many patients report penicillin allergies but clinically significant IgE-mediated or T-cell-mediated penicillin hypersensitivity is uncommon (<5%) 6
  • Avoiding appropriate cephalosporins in penicillin-allergic patients may lead to the use of broader-spectrum antibiotics, increasing the risk of antimicrobial resistance and adverse events 6
  • IgE-mediated penicillin allergy wanes over time, with 80% of patients becoming tolerant after a decade 6
  • Both the nuclear structure and R1 side-chain contribute to IgE recognition, meaning cross-reactivity can occur with both first-generation and third-generation cephalosporins 4

Algorithm for Decision Making

  1. Determine if the patient has a true penicillin allergy (less than 5% of those with penicillin allergy labels have a true allergy) 5
  2. Identify the specific penicillin that caused the reaction (particularly if it was amoxicillin or ampicillin) 1, 5
  3. Assess the type of previous reaction:
    • For immediate-type reactions: Avoid cephalexin if the reaction was severe or occurred within the last 5 years 1
    • For delayed-type reactions: Avoid cephalexin if the reaction was to amoxicillin 1
  4. Consider alternative cephalosporins with dissimilar side chains (like cefazolin) which have negligible cross-reactivity risk 1
  5. If cephalexin must be used in a patient with non-severe penicillin allergy >5 years ago, administer in a controlled setting prepared to manage potential allergic reactions 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cephalosporin and penicillin cross-reactivity in patients allergic to penicillins.

International journal of clinical pharmacology and therapeutics, 2011

Research

The Use of Perioperative Cephalexin in Penicillin Allergic Patients in Dermatologic Surgery: An Advisory Statement.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.